GTPBP1
GTP-binding protein 1
Also known as: GP-1, GTPB1_HUMAN, HSPC018
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O00178
- Gene
- GTPBP1
- Ensembl
- ENSG00000100226
- Chromosome
- 22
- Canonical length
- 669 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nuclear bodies,Golgi apparatus,Cytosol
OverviewNCBI Gene
This gene is upregulated by interferon-gamma and encodes a protein that is a member of the AGP11/GTPBP1 family of GTP-binding proteins. A structurally similar protein has been found in mouse, where disruption of the gene for that protein had no observable phenotype. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
669 residues, UniProt reviewed canonical sequence.
>O00178|GTPBP1
1 MATERSRSAM DSPVPASMFA PEPSSPGAAR AAAAAARLHG GFDSDCSEDG EALNGEPELD
61 LTSKLVLVSP TSEQYDSLLR QMWERMDEGC GETIYVIGQG SDGTEYGLSE ADMEASYATV
121 KSMAEQIEAD VILLRERQEA GGRVRDYLVR KRVGDNDFLE VRVAVVGNVD AGKSTLLGVL
181 THGELDNGRG FARQKLFRHK HEIESGRTSS VGNDILGFDS EGNVVNKPDS HGGSLEWTKI
241 CEKSTKVITF IDLAGHEKYL KTTVFGMTGH LPDFCMLMVG SNAGIVGMTK EHLGLALALN
301 VPVFVVVTKI DMCPANILQE TLKLLQRLLK SPGCRKIPVL VQSKDDVIVT ASNFSSERMC
361 PIFQISNVTG ENLDLLKMFL NLLSPRTSYR EEEPAEFQID DTYSVPGVGT VVSGTTLRGL
421 IKLNDTLLLG PDPLGNFLSI AVKSIHRKRM PVKEVRGGQT ASFALKKIKR SSIRKGMVMV
481 SPRLNPQASW EFEAEILVLH HPTTISPRYQ AMVHCGSIRQ TATILSMDKD CLRTGDKATV
541 HFRFIKTPEY LHIDQRLVFR EGRTKAVGTI TKLLQTTNNS PMNSKPQQIK MQSTKKGPLT
601 KRDEGGPSGG PAVGAPPPGD EASSVGAGQP AASSNLQPQP KPSSGGRRRG GQRHKVKSQG
661 ACVTPASGCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GTPBP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 100 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 100 nTPM
- retina: 32 nTPM
- skeletal muscle: 30 nTPM
- lung: 29 nTPM
- spleen: 28 nTPM
- skin: 27 nTPM
Single-cell type
- neutrophils: 720 nCPM
- neutrophil progenitors: 163 nCPM
- esophageal apical cells: 92 nCPM
- enterocytes: 89 nCPM
- pdcs: 89 nCPM
- plasma cells: 89 nCPM
Immune cell
- neutrophil: 7.7 nTPM
- non-classical monocyte: 5 nTPM
- memory CD8 T-cell: 4.9 nTPM
- gdT-cell: 4.6 nTPM
- intermediate monocyte: 4.6 nTPM
- memory B-cell: 4.6 nTPM
Brain region
- cerebral cortex: 103 nTPM
- white matter: 54 nTPM
- choroid plexus: 49 nTPM
- medulla oblongata: 47 nTPM
- cerebellum: 47 nTPM
- hypothalamus: 45 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GTPBP1.
Disease | AllUniProt
Conditions GTPBP1 is implicated in, by any mechanism.
- Neurodevelopmental disorder with characteristic facial and ectodermal features and tetraparesis 1 (NEDFET1) MIM:620888
Disease | GeneticClinVar
4 pathogenic / likely-pathogenic of 90 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Neurodevelopmental disorder with characteristic facial and ectodermal features and tetraparesis 1
Disease | AutoantibodyPubMed
Conditions in which antibodies against GTPBP1 are reported. Each links to that disease's full target list.
ReferencesPubMed · IEDB
Publications for GTPBP1 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
11 publications
- The association between antiphospholipid antibodies and placenta mediated complications: a systematic review and meta-analysis.
2011 · Thromb Res · RCR 4.7 · 128 citations - Autoantibodies to domain 1 of beta 2 glycoprotein 1: a promising candidate biomarker for risk management in antiphospholipid syndrome.
2012 · Autoimmun Rev · RCR 2.9 · 78 citations - Prognostic analysis of antibody typing and treatment for antiphospholipid syndrome-related recurrent spontaneous abortion.
2022 · Int J Gynaecol Obstet · RCR 1.5 · 13 citations - Value of autoantibodies to beta(2)-glycoprotein 1 in the diagnosis of antiphospholipid syndrome.
2002 · Rheumatology (Oxford) · RCR 1.1 · 36 citations - Patient-derived monoclonal antibodies directed towards beta2 glycoprotein-1 display lupus anticoagulant activity.
2011 · J Thromb Haemost · RCR 0.9 · 25 citations
Show 6 more
- Antiphospholipid and other autoantibodies in a cohort of habitual aborters and healthy multiparous women in Jamaica.
2011 · Hum Antibodies · RCR 0.4 · 10 citations - Effects of antiphospholipid antibodies on in vitro platelet aggregation.
2012 · Clin Appl Thromb Hemost · RCR 0.4 · 9 citations - IgG antibodies to plasminogen and their relationship to IgG anti-beta(2)-glycoprotein 1 antibodies and thrombosis.
2008 · Clin Rheumatol · RCR 0.3 · 9 citations - A possible coagulation-independent mechanism for pregnancy loss involving β(2) glycoprotein 1-dependent antiphospholipid antibodies and CD1d.
2012 · Am J Reprod Immunol · RCR 0.2 · 6 citations - Selection of thrombogenetic antiphospholipid antibodies in cerebrovascular disease patients.
2003 · J Neurol · RCR 0.1 · 4 citations - Anti tissue transglutaminase antibody in idiopathic autoimmune haemolytic anemia.
2019 · Transfus Apher Sci · RCR 0.1 · 1 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.35
- gnomAD pLI
- 0.93
- gnomAD missense Z
- 3.36
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cytoplasmic translation
- GTP metabolic process
- immune response
- positive regulation of mRNA catabolic process
- RNA surveillance
- signal transduction
- translational elongation
Molecular functions
- alpha-aminoacyl-tRNA binding
- GTP binding
- GTPase activity
- RNA binding
- translation elongation factor activity
- tRNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Translational (tr)-type GTP-binding domain
- Translation elongation factor EFTu-like, domain 2
- Translation protein, beta-barrel domain superfamily
- Translation elongation factor EF1A/initiation factor IF2gamma, C-terminal
- P-loop containing nucleoside triphosphate hydrolase
- GTP binding protein 1-like, GTP-binding domain
- Elongation factor Tu GTPase
- Elongation factor Tu GTP binding domain
- Elongation factor Tu domain 2
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GTPBP1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GTPBP1 as an antibody target. Whether an autoantibody or antibody against GTPBP1 could matter depends on whether native GTPBP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GTPBP1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GTPBP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...